Management of diabetic gastroparesis.
| dc.contributor.author | Mukhopadhyay, Pradip | en_US |
| dc.contributor.author | Basu, A K | en_US |
| dc.date.accessioned | 2005-03-22 | en_US |
| dc.date.accessioned | 2009-05-31T10:47:41Z | |
| dc.date.available | 2005-03-22 | en_US |
| dc.date.available | 2009-05-31T10:47:41Z | |
| dc.date.issued | 2005-03-22 | en_US |
| dc.description | 2 references. | en_US |
| dc.description.abstract | Diabetic gastroparesis is a long term complication of diabetes mellitus which could basically be defined as dysregulated gastric emptying leading to various pathological, biochemical and clinical changes in absence of any structural changes. Symptoms include nausea, vomiting, bloating, epigastric pain, anorexia, weight loss and so on. For symptomatic gastroparesis prokinetic drugs like metoclopramide, domperidone, cisapride, erythromycin and itcopride are used. Itopride is currently emerging as a prokinetic drug of choice. There is also scope of surgery. | en_US |
| dc.description.affiliation | Department of Endocrinology, Medical College, Kolkata. | en_US |
| dc.identifier.citation | Mukhopadhyay P, Basu AK. Management of diabetic gastroparesis. Journal of the Indian Medical Association. 2005 Mar; 103(3): 184, 186 | en_US |
| dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/99697 | |
| dc.language.iso | eng | en_US |
| dc.source.uri | https://www.jimaonline.org.in/ | en_US |
| dc.subject.mesh | Diabetes Complications --diagnosis | en_US |
| dc.subject.mesh | Dopamine Antagonists --therapeutic use | en_US |
| dc.subject.mesh | Gastrointestinal Agents --therapeutic use | en_US |
| dc.subject.mesh | Gastroparesis --diagnosis | en_US |
| dc.subject.mesh | Humans | en_US |
| dc.subject.mesh | Serotonin Agonists --therapeutic use | en_US |
| dc.title | Management of diabetic gastroparesis. | en_US |
| dc.type | Journal Article | en_US |
| dc.type | Review | en_US |
Files
License bundle
1 - 1 of 1